Repurposing of phosphodiesterase-5 inhibitor sildenafil as a therapeutic agent to prevent gastric cancer growth through suppressing c-MYC stability for IL-6 transcription
Abstract Phosphodiesterase-5 (PDE5) inhibitors have shown promise as anti-cancer agents in malignancies. However, their specific effects on gastric cancer (GC) and the underlying mechanisms remain elusive. Our aim was to investigate this by combining evidence from population-based studies with data...
Saved in:
Main Authors: | Zhenzhan Zhang, Wuqing Huang, Donghua Huang, Zhou Xu, Qingfeng Xie, Xin Tan, Wenjun He, Weihao Yang, Guoxin Li, Jianguang Ji, Hao Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-025-07519-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dysbiosis of Gastric Mucosal Fungal Microbiota in the Gastric Cancer Microenvironment
by: Zhenzhan Zhang, et al.
Published: (2022-01-01) -
The role of phosphodiesterase 4B in IL-8/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor
by: Suzuki Osamu, et al.
Published: (2015-06-01) -
EI24 Suppresses Tumorigenesis in Pancreatic Cancer via Regulating c-Myc
by: Yi Zang, et al.
Published: (2018-01-01) -
Sildenafil Treatment of Primary Pulmonary Hypertension
by: Kevin B Laupland, et al.
Published: (2003-01-01) -
Transcription Factor E2F-1 Is Upregulated in Human Gastric Cancer Tissues and Its Overexpression Suppresses Gastric Tumor Cell Proliferation
by: Qiang Xiao, et al.
Published: (2007-01-01)